The overexpression of MYC is generally associated with a poor prognosis in various cancers. High levels of MYC correlate with aggressive tumor behavior, resistance to therapy, and higher chances of recurrence. Consequently, MYC can serve as both a prognostic marker and a potential therapeutic target in cancer treatment.
